
NEURODERM.COM
NeuroDerm – Continuous TherapyManagement and Key Employees. ND0612L for moderate PD. ND0612H for severe PD. ND0701 for severe PD. ND0612 ongoing clinical trials. Risks related to ND0612 clinical studies. Management and Key Employees. ND0612L for moderate PD. ND0612H for severe PD. ND0701 for severe PD. ND0612 ongoing clinical trials. Risks related to ND0612 clinical studies. NeuroDerm Ongoing Clinical Trials – Patient Information. NeuroDerm announced that it has signed a definitive agreement under which Mitsubishi Tanabe Pharma Corpo...
http://www.neuroderm.com/